Beta Cell Dysfunction Prior to Clinical Type 1 Diabetes Onset
Level 2, Ernest N. Morial Convention Center
Q&A with Emily K. Sims, MD
Associate Professor of Pediatrics,
Indiana University School of Medicine
What is your presentation about?
This presentation will elaborate on ways in which understanding and application of measures of beta cell dysfunction could help understand type 1 diabetes prevention efforts.
What makes this topic important in 2022?
Development of biomarkers and beta cell-targeted therapeutics could allow for a more tailored approach to treatment of patients with or at-risk for type 1 diabetes.
How did you become involved with this area of diabetes research or care?
As a pediatric endocrinologist, I provide care for patients with type 1 diabetes.
What are you most looking forward to at the 82nd Scientific Sessions?
Networking with colleagues in person.